Ultrasound Therapy In Cardiac Amyloidosis
study id #: NCT04667494
condition: Amyloidosis Cardiac
status: Recruiting
purpose:This is a prospective pilot clinical study of subjects with cardiac amyloidosis and control subjects without amyloidosis where we plan to evaluate changes in myocardial blood flow, systolic and diastolic function before and after sonotherapy.
intervention: Sonotherapy
results: https://clinicaltrials.gov/ct2/show/results/NCT04667494
last updated: February 22, 2024
-
Managing AL Treatment Side Effects by Dr. Morie Gertz – ASG Webinar – 1/9https://www.youtube.com/watch?v=vP4wvJq5...
-
The Patient Journey Toward a Diagnosis of Hereditary Transthyretin (ATTRv) AmyloidosisBackground: Despite emerging treatments...
-
J. Emanuel Finet, MDJ. Emanuel Finet is a staff physician in...
-
Continuing With Your Career After hATTR Amyloidosis DiagnosisIt is important to talk to your employ...
-
How to Talk With Your Family Members About Your hATTR Diagnosishttps://www.oneamyloidosisvoice.com/wp-c...
-
Pathophysiology and Treatment of Cardiac AmyloidosisAmyloid cardiomyopathy should be suspect...
-
Treatment Considerations for Patients Exceeding 10% Plasma Cells – ASG Webinar 11/13https://www.youtube.com/watch?v=4gUXPbOk...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.